Search

everythinglearnresearchcommunity

for

Search:↓

Lupus and frontal fibrosing alopecia may share a common cause.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

The patient has frontal fibrosing alopecia (FFA).

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Dermoscopy helps diagnose frontal fibrosing alopecia by identifying specific scalp features.

Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

A genetic marker linked to a type of hair loss was found in most patients studied.

The study found that males with KFSD had severe skin and eye symptoms, while female carriers had milder symptoms.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Methotrexate may help stabilize frontal fibrosing alopecia.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

More research is needed to better understand and treat Fibrosing Frontal Alopecia.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.